122
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Assessment of Streptococcus pneumoniae Capsule in Conjunctivitis and Keratitis in vivo Neuraminidase Activity Increases in Nonencapsulated Pneumococci following Conjunctival Infection

, , , &
Pages 787-798 | Received 01 Mar 2010, Accepted 06 May 2010, Published online: 26 Aug 2010

REFERENCES

  • Jedrzejas MJ. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev. 2001;65:187–207.
  • Bhave P, Chamie G. Streptococcus pneumoniae keratitis. J Hosp Med. 2008;3:353.
  • Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiology of bacterial keratitis in a referral centre in South India. Indian J Med Microbiol. 2003;21:239–245.
  • Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med. 2003;348:1112–1121.
  • Crum NF, Barrozo CP, Chapman FA, et al. An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees. Clin Infect Dis. 2004;39:1148–1154.
  • Buck JM, Lexau C, Shapiro M, et al. A community outbreak of conjunctivitis caused by nontypeable Streptococcus pneumoniae in Minnesota. Pediatr Infect Dis J. 2006;25:906–911.
  • Tarabishy AB, Jeng BH. Bacterial conjunctivitis: A review for internists. Cleve Clin J Med. 2008;75:507–512.
  • Dada T, Sharma N, Dada VK, et al. Pneumococcal keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2000;26:460–461.
  • Jhanji V, Moorthy S, Vajpayee RB. Microbial keratitis in patients with down syndrome: A retrospective study. Cornea. 2009;28:163–165.
  • Holden BA, Sweeney DF, Sankaridurg PR, et al. Microbial keratitis and vision loss with contact lenses. Eye Contact Lens. 2003;29:S131–S134..
  • Saeed A, D’Arcy F, Stack J, et al. Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea. 2009;28:285–292.
  • Wagoner MD, Al-Ghamdi AH, Al-Rajhi AA. Bacterial keratitis after primary pediatric penetrating keratoplasty. Am J Ophthalmol. 2007;143:1045–1047.
  • Norina TJ, Raihan S, Bakiah S, et al. Microbial keratitis: Aetiological diagnosis and clinical features in patients admitted to Hospital Universiti Sains Malaysia. Singapore Med J. 2008;49:67–71.
  • Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial keratitis in South India: Influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14:61–69.
  • Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24:823–828.
  • Di BS, Higa M, Janer M, et al. [Neonatal conjunctivitis in a hospital at Gran Buenos Aires. Last 5 years up-date]. Rev Argent Microbiol. 2005;37:139–141.
  • Patel PB, Diaz MC, Bennett JE, et al. Clinical features of bacterial conjunctivitis in children. Acad Emerg Med. 2007;14:1–5.
  • Epling J. Bacterial conjunctivitis. Clin Evid (Online). 2007.
  • Bodor FF. Conjunctivitis-otitis syndrome. Pediatrics. 1982;69:695–698.
  • Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol. 2009;9:13.
  • Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49:1–35.
  • Hyams C, Camberlein E, Cohen JM, et al. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun. 2010;78:704–715.
  • Li J, Szalai AJ, Hollingshead SK, et al. Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages. Infect Immun. 2009;77:464–471.
  • Watson DA, Musher DM. Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun. 1990;58:3135–3138.
  • Magee AD, Yother J. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun. 2001;69:3755–3761.
  • Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997;81:965–971.
  • Reed JM, O’Callaghan RJ, Girgis DO, et al. Ocular virulence of capsule-deficient Streptococcus pneumoniae in a rabbit keratitis model. Invest Ophthalmol Vis Sci. 2005;46:604–608.
  • Shayegani M, Parsons LM, Gibbons WE, Jr.,et al. Characterization of nontypeable Streptococcus pneumoniae-like organisms isolated from outbreaks of conjunctivitis. J Clin Microbiol. 1982;16:8–14.
  • Carvalho MG, Steigerwalt AG, Thompson T, et al. Confirmation of nontypeable Streptococcus pneumoniae-like organisms isolated from outbreaks of epidemic conjunctivitis as Streptococcus pneumoniae. J Clin Microbiol. 2003;41:4415–4417.
  • Williamson YM, Gowrisankar R, Longo DL, et al. Adherence of nontypeable Streptococcus pneumoniae to human conjunctival epithelial cells. Microb Pathog. 2008;44:175–185.
  • Manco S, Hernon F, Yesilkaya H, et al. Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect Immun. 2006;74:4014–4020.
  • Uchiyama S, Carlin AF, Khosravi A, et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med. 2009;206:1845–1852.
  • Gut H, King SJ, Walsh MA. Structural and functional studies of Streptococcus pneumoniae neuraminidase B: An intramolecular trans-sialidase. FEBS Lett. 2008;582:3348–3352.
  • Pettigrew MM, Fennie KP, York MP, et al. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect Immun. 2006;74:3360–3365.
  • Lock RA, Paton JC, Hansman D. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae. Microb Pathog. 1988;5:461–467.
  • Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44:124–131.
  • Sung CK, Li H, Claverys JP, et al. An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol. 2001;67:5190–5196.
  • Pozzi G, Masala L, Lannelli F, et al. Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: Two allelic variants of the peptide pheromone. J Bacteriol. 1996;178:6087–6090.
  • Johnson MK, Hobden JA, Hagenah M, et al. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res. 1990;9:1107–1114.
  • Kloosterman TG, van der Kooi-Pol MM, Bijlsma JJ, et al. The novel transcriptional regulator SczA mediates protection against Zn2+ stress by activation of the Zn2+-resistance gene czcD in Streptococcus pneumoniae. Mol Microbiol. 2007;65:1049–1063.
  • Gupta R, Shah P, Swiatlo E. Differential gene expression in Streptococcus pneumoniae in response to various iron sources. Microb Pathog. 2009;47:101–109.
  • Hammerschmidt S, Wolff S, Hocke A, et al. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73:4653–4667.
  • Green SN, Sanders M, Moore QC, III, et al. Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Invest Ophthalmol Vis Sci. 2008;49:290–294.
  • Dajcs JJ, Thibodeaux BA, Girgis DO, et al. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. DNA Cell Biol. 2002;21:375–382.
  • Guzek JP, Cline DJ, Row PK, et al. Rabbit Streptococcus pneumoniae keratitis model and topical therapy. Invest Ophthalmol Vis Sci. 1998;39:2012–2017.
  • Royle L, Matthews E, Corfield A, et al. Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J. 2008;25:763–773.
  • Hyndiuk RA. Experimental Pseudomonas keratitis. Trans Am Ophthalmol Soc. 1981;79:541–624.
  • Aristoteli LP, Willcox MD. The adhesion of Pseudomonas aeruginosa to high molecular weight human tear film species corresponds to glycoproteins reactive with Sambucus nigra lectin. Exp Eye Res. 2006;83:1146–1153.
  • Rhim AD, Stoykova L, Glick MC, et al. Terminal glycosylation in cystic fibrosis (CF): A review emphasizing the airway epithelial cell. Glycoconj J. 2001;18:649–659.
  • McNamara NA, Andika R, Kwong M, et al. Interaction of Pseudomonas aeruginosa with human tear fluid components. Curr Eye Res. 2005;30:517–525.
  • Hyams C, Yuste J, Bax K, et al. Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype. Infect Immun. 2010;78:716–725.
  • Medeiros MI, Neme SN, da SP, et al. Streptococcus pneumoniae and Haemophilus influenzae as etiological agents of conjunctivitis outbreaks in the region of Ribeirao Preto, SP, Brazil. Rev Inst Med Trop Sao Paulo. 1998;40:7–9.
  • Hammerschmidt S. Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol. 2006;9:12–20.
  • Bootsma HJ, Egmont-Petersen M, Hermans PW. Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: Evidence for a distinct response to encapsulated strains. Infect Immun. 2007;75:5489–5499.
  • Berry AM, Paton JC. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun. 2000;68:133–140.
  • Papasergi S, Garibaldi M, Tuscano G, et al. Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells. J Biol Chem. 2010;285:7517–7524.
  • Johnson MK, Hobden JA, O’Callaghan RJ, et al. Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res. 1992;11:1221–1225.
  • Jounblat R, Kadioglu A, Mitchell TJ, et al. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect Immun. 2003;71:1813–1819.
  • Paton JC, Rowan-Kelly B, Ferrante A. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun. 1984;43:1085–1087.
  • Rubins JB, Charboneau D, Fasching C, et al. Distinct roles for pneumolysin’s cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med. 1996;153:1339–1346.
  • Rubins JB, Janoff EN. Pneumolysin: A multifunctional pneumococcal virulence factor. J Lab Clin Med. 1998;131:21–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.